Glenmark PharmaceuticalsGLENMARK 
$19.67-3.91%24h
-3.91%24h
Global rank2567
Market cap$5.55B
Change 7d-5.67%
YTD Performance92.75%
SP500 benchmarkOutperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Market capitalization of Glenmark Pharmaceuticals (GLENMARK)
As of November 2024, Glenmark Pharmaceuticals has a market cap of $5.55B. This makes Glenmark Pharmaceuticals the world's 2567th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Glenmark Pharmaceuticals from 2002 to 2024
-
Value:-
Market cap history of Glenmark Pharmaceuticals from 2002 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $2.73B | -5.12% |
| 2023 | $2.88B | 101.33% |
| 2022 | $1.43B | -19.75% |
| 2021 | $1.78B | 7.10% |
| 2020 | $1.66B | 42.03% |
| 2019 | $1.17B | -49.87% |
| 2018 | $2.34B | 16.53% |
| 2017 | $2.01B | -33.06% |
| 2016 | $3.00B | -3.63% |
| 2015 | $3.11B | 19.70% |
| 2014 | $2.60B | 44.27% |
| 2013 | $1.80B | 1.00% |
| 2012 | $1.78B | 80.05% |
| 2011 | $989.72M | -18.93% |
| 2010 | $1.22B | 31.27% |
| 2009 | $930.04M | -6.84% |
| 2008 | $998.32M | -50.32% |
| 2007 | $2.01B | 295.55% |
| 2006 | $508.01M | 92.22% |
| 2005 | $264.29M | 29.33% |
| 2004 | $204.36M | 238.85% |
| 2003 | $60.31M | 1391.25% |
| 2002 | $4.04M | - |
GLENMARK Market Cap Today is $5.55B -3.91% - 20 Nov 2024
View largest stocks by market cap 
